These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 11263918)
1. Asymmetric synthesis of the northern half C1-C16 of the bryostatins. Vakalopoulos A; Lampe TF; Hoffmann HM Org Lett; 2001 Mar; 3(6):929-32. PubMed ID: 11263918 [TBL] [Abstract][Full Text] [Related]
2. Synthetic studies on the bryostatins: synthetic routes to analogues containing the tricyclic macrolactone core. Keck GE; Truong AP Org Lett; 2005 May; 7(11):2153-6. PubMed ID: 15901157 [TBL] [Abstract][Full Text] [Related]
3. New, abridged pathway to Masamune's "southern hemisphere" intermediate for the total synthesis of bryostatin 7. Hale KJ; Frigerio M; Manaviazar S Org Lett; 2003 Feb; 5(4):503-5. PubMed ID: 12583754 [TBL] [Abstract][Full Text] [Related]
4. An aldol approach to the synthesis of the EF fragment of spongistatin 1. Crimmins MT; Katz JD; McAtee LC; Tabet EA; Kirincich SJ Org Lett; 2001 Mar; 3(6):949-52. PubMed ID: 11263923 [TBL] [Abstract][Full Text] [Related]
5. A new synthetic approach to the C ring of known as well as novel bryostatin analogues. Wender PA; Koehler MF; Sendzik M Org Lett; 2003 Nov; 5(24):4549-52. PubMed ID: 14627380 [TBL] [Abstract][Full Text] [Related]
6. Control of olefin geometry in the bryostatin B-ring through exploitation of a C(2)-symmetry breaking tactic and a Smith-Tietze coupling reaction. Hale KJ; Hummersone MG; Bhatia GS Org Lett; 2000 Jul; 2(15):2189-92. PubMed ID: 10930240 [TBL] [Abstract][Full Text] [Related]
7. Chemistry and clinical biology of the bryostatins. Mutter R; Wills M Bioorg Med Chem; 2000 Aug; 8(8):1841-60. PubMed ID: 11003129 [TBL] [Abstract][Full Text] [Related]
8. A concise, selective synthesis of the polyketide spacer domain of a potent bryostatin analogue. Wender PA; Mayweg AV; VanDeusen CL Org Lett; 2003 Feb; 5(3):277-9. PubMed ID: 12556171 [TBL] [Abstract][Full Text] [Related]
9. The rational design of potential chemotherapeutic agents: synthesis of bryostatin analogues. Wender PA; Hinkle KW; Koehler MF; Lippa B Med Res Rev; 1999 Sep; 19(5):388-407. PubMed ID: 10502742 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of the bryostatin 1 northern hemisphere (C1-C16) via desymmetrization by ketalization/ring-closing metathesis. Voight EA; Seradj H; Roethle PA; Burke SD Org Lett; 2004 Oct; 6(22):4045-8. PubMed ID: 15496095 [TBL] [Abstract][Full Text] [Related]
11. The chemistry and biology of the bryostatin antitumour macrolides. Hale KJ; Hummersone MG; Manaviazar S; Frigerio M Nat Prod Rep; 2002 Aug; 19(4):413-53. PubMed ID: 12195811 [TBL] [Abstract][Full Text] [Related]
12. The bryostatins. Pettit GR Fortschr Chem Org Naturst; 1991; 57():153-195. PubMed ID: 1937312 [No Abstract] [Full Text] [Related]
13. Synthesis of the C29-C44 portion of spongistatin 1 (altohyrtin A). Wallace GA; Scott RW; Heathcock CH J Org Chem; 2000 Jun; 65(13):4145-52. PubMed ID: 10866633 [TBL] [Abstract][Full Text] [Related]
14. Total synthesis of the potent microtubule-stabilizing agent (+)-discodermolide. Harried SS; Lee CP; Yang G; Lee TI; Myles DC J Org Chem; 2003 Aug; 68(17):6646-60. PubMed ID: 12919029 [TBL] [Abstract][Full Text] [Related]
15. Stereoselective total synthesis of antitumor macrolide (+)-rhizoxin D. Jiang Y; Hong J; Burke SD Org Lett; 2004 Apr; 6(9):1445-8. PubMed ID: 15101763 [TBL] [Abstract][Full Text] [Related]
16. A short synthetic pathway to a fully-functionalized southern hemisphere of the antitumor macrolide bryostatin 1. Hale KJ; Frigerio M; Manaviazar S Org Lett; 2001 Nov; 3(23):3791-4. PubMed ID: 11700140 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of the C1-C12 fragment of the tedanolides. Aldol-non-aldol aldol approach. Jung ME; Yoo D Org Lett; 2007 Aug; 9(18):3543-6. PubMed ID: 17676748 [TBL] [Abstract][Full Text] [Related]
18. Total synthesis of (+)-spongistatin 1. An effective second-generation construction of an advanced EF Wittig salt, fragment union, and final elaboration. Smith AB; Zhu W; Shirakami S; Sfouggatakis C; Doughty VA; Bennett CS; Sakamoto Y Org Lett; 2003 Mar; 5(5):761-4. PubMed ID: 12605509 [TBL] [Abstract][Full Text] [Related]
19. Synthetic studies on the bryostatins: preparation of a truncated BC-ring intermediate by pyran annulation. Keck GE; Truong AP Org Lett; 2005 May; 7(11):2149-52. PubMed ID: 15901156 [TBL] [Abstract][Full Text] [Related]
20. Chemistry. The renaissance of natural products as drug candidates. Paterson I; Anderson EA Science; 2005 Oct; 310(5747):451-3. PubMed ID: 16239465 [No Abstract] [Full Text] [Related] [Next] [New Search]